What Makes a Drug “AI-Developed”?
SMRTR summary
AI is speeding up and reducing costs in drug development, enhancing all stages from target identification to clinical trials, although no drug has been entirely created by AI without human involvement yet.
SMRTR provides this summary for quick context. The original article belongs to Medium.
Read the original article